Order Article Reprints

Vincent MD, Breadner D, Cripps MC, Jonker DJ, Klimo P, Biagi JJ, Lam W, O’Connell A, Whiston F, Stitt L, et al. Phase I/II Trial of Dose-Reduced Capecitabine in Elderly Patients with Advanced Colorectal Cancer. Current Oncology. 2017; 24(4):261-268. https://doi.org/10.3747/co.24.3516

Vincent, M.D., D. Breadner, M.C. Cripps, D.J. Jonker, P. Klimo, J.J. Biagi, W. Lam, A. O’Connell, F. Whiston, L. Stitt, and et al. 2017. "Phase I/II Trial of Dose-Reduced Capecitabine in Elderly Patients with Advanced Colorectal Cancer" Current Oncology 24, no. 4: 261-268. https://doi.org/10.3747/co.24.3516

Vincent, M. D., Breadner, D., Cripps, M. C., Jonker, D. J., Klimo, P., Biagi, J. J., Lam, W., O’Connell, A., Whiston, F., Stitt, L., & Welch, S. A. (2017). Phase I/II Trial of Dose-Reduced Capecitabine in Elderly Patients with Advanced Colorectal Cancer. Current Oncology, 24(4), 261-268. https://doi.org/10.3747/co.24.3516